Milian-Hernández EJ, Anzules-Guerra JB, Betancourt-Castellanos L, Colón-Núñez S, Zapata-Cevallos SI

Language: Spanish
References: 13
Page: 209-213
PDF size: 325.05 Kb.

ABSTRACT

BRASH syndrome results as a consequence of a chain of pathophysiological events that generally occurs in elderly patients, with underlying cardiac disease, treated with beta-blockers or calcium channel blockers, and who present hyperkalemia. This combination of events potentiates the adverse effects of these drugs, thus, bradycardia, hypoperfusion and shock may develop. We present the case of a 78-year-old male patient with a history of high blood pressure, diabetes mellitus and stage II chronic kidney disease, who was being treated with carvedilol and who attended the emergency department presenting the clinical features that character-ize the syndrome. Despite the implantation of a temporary transvenous pacemak-er, he died a few hours later. In this report is highlighted the importance of recog-nizing the factors that lead to the appearance of this syndrome, and the multimod-al treatment that these patients need as part of the therapeutic protocol.

REFERENCES

1. Chacón N, Calderón A, Haro C. Síndrome deBRASH: bradicardia, falla renal, bloqueo auricu-loventricular, shock e hiperkalemia. Reporte de un caso. Ciencia Digital [Internet]. 2018 [citado 30 Jun 2021];2(2):567-80. Disponible en:https://doi. org/10. 33262/cienciadigital. v2i2. 120

2. Farkas JD, Long B, Koyfman A, Menson K. BRASH Syndrome: Bradycardia, Renal Failure, AV Block-ade, Shock, and Hyperkalemia. J Emerg Med. 2020;59(2):216-23. [DOI]

3. Srivastava S, Kemnic T, Hildebrandt KR. BRASH syndrome. BMJ Case Rep [Internet]. 2020 [citado 1 Jul 2021];13(2):e233825. Disponible en:https://doi. org/10. 1136/bcr-2019-233825

4. Aziz EF, Javed F, Korniyenko A, Pratap B, Cordo-va JP, Alviar CL, et al. Mild hyperkalemia and low eGFR a tedious recipe for cardiac disaster in the elderly: an unusual reversible cause of syncope and heart block. Heart Int [Internet]. 2011 [citado 1 Jul 2021];6(2):e12. Disponible en:https://doi. org/10. 4081/hi. 2011. e12

5. Gonuguntla K, Patil S, Manek G, Tandon V, Kaur A. Brash syndrome: lost in plain sight. Chest Journal [Internet]. 2019 [citado 1 Jul 2021];156(4): A2228. Disponible en:http://dx. doi. org/10. 1016/j. chest. 2019. 08. 2152

6. Sohal S, Ramachandran A. Syndrome of brady-cardia, renal failure, atrioventricular nodal block-ers, shock, and hyperkalemia (brash syndrome): a new clinical entity? Chest Journal [Internet]. 2019 [citado 1 Jul 2021];156(4):A74. Disponible en: https://doi. org/10. 1016/j. chest. 2019. 08. 168

7. Hanumanthu BKJ, Chugh Y, Grushko M, Faillace RT. Hyperkalemia Presenting as Sinus Bradycar-dia, Junctional Rhythm and Atrial Bigeminy. Cu-reus [Internet]. 2019 [citado 2 Jul 2021];11(12): e6439. Disponible en:https://doi. org/10. 7759/cureus. 6439

8. Arai R, Fukamachi D, Monden M, Akutsu N, Mu-rata N, Okumura Y. Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibril-lation and Chronic Kidney Disease. Intern Med [Internet]. 2021 [citado 2 Jul 2021];60(1):79-83. Dis- ponible en:https://doi. org/10. 2169/internalmedicine. 5598-20

9. Arif AW, Khan MS, Masri A, Mba B, Talha Ayub M, Doukky R. BRASH Syndrome with Hyperkale-mia: An Under-Recognized Clinical Condition. Methodist Debakey Cardiovasc J. 2020;16(3):241-4. [DOI]

10. Grados D, Gracia A, Gracia C, Toribio B, León E, Martínez C, et al. Disfunción sinusal transitoria secundaria a tratamiento con lacosamida. CorSa-lud [Internet]. 2019 [citado 2 Jul 2021];11(2):167-70. Disponible en:http://www. revcorsalud. sld. cu/index. php/cors/article/view/370

11. Carmona R, Lorenzo E. El nodo sinusal normal: Lo que ahora sabemos. CorSalud [Internet]. 2020 [citado 3 Jul 2021];12(4):415-24. Disponible en:http://www. revcorsalud. sld. cu/index. php/cors/article/view/736/1318

12. Long B, Warix JR, Koyfman A. Controversies in Management of Hyperkalemia. J Emerg Med. 2018; 55(2):192-205. [DOI]

13. Broz J, Urbanova J, Nunes M, Brabec M, Brune-rova L. "Controversies in Management of Hyper-kalemia": Remarks on the Risk of Hyperglycemia. J Emerg Med. 2019;56(4):458-9. [DOI]